Loading...
XLON
NIOX
Market cap393mUSD
Dec 05, Last price  
70.20GBP
1D
-1.68%
1Q
-4.88%
Jan 2017
-25.32%
IPO
-77.35%
Name

Niox Group PLC

Chart & Performance

D1W1MN
XLON:NIOX chart
P/E
79.72
P/S
7.06
EPS
0.01
Div Yield, %
1.42%
Shrs. gr., 5y
3.26%
Rev. gr., 5y
5.05%
Revenues
42m
-10.77%
000015,918,12128,543,50262,632,31561,514,87045,836,37432,670,08937,715,22037,854,22036,800,00046,846,40041,800,000
Net income
4m
-65.42%
-14,513,000-15,498,000-19,981,000-35,100,000-73,547,618-169,654,673-134,057,505-149,138,537-63,985,459-45,792,8034,866,48016,100,00010,700,00010,700,0003,700,000
CFO
17m
+10.75%
-13,986,000-18,325,000-17,881,000-36,900,000-77,821,929-69,196,370-76,565,638-51,071,352-32,721,342-32,670,0891,892,5198,223,92011,600,00015,530,59917,200,000
Dividend
May 23, 20241 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

NIOX Group Plc, a diagnostics and management company, provides point-of-care fractional exhaled nitric oxide (FeNo) diagnosis and management products worldwide. Its products include NIOX VERO, a portable system for the non-invasive measurement of nitric oxide in human breath. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
IPO date
Mar 13, 2014
Employees
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2024‑122023‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT